141 related articles for article (PubMed ID: 32651961)
1. Updates on the Pharmacology of Chloroquine against Coronavirus Disease 2019 (COVID-19): A Perspective on its Use in the General and Geriatric Population.
Yao X; Hou Z; Cui C; Zhang M; Tu S; Li H; Liu D
Curr Drug Metab; 2020; 21(7):534-540. PubMed ID: 32651961
[TBL] [Abstract][Full Text] [Related]
2. Of chloroquine and COVID-19.
Touret F; de Lamballerie X
Antiviral Res; 2020 May; 177():104762. PubMed ID: 32147496
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological characteristics of chloroquine and suggestions for its use in treatment of coronavirus disease 2019 (COVID-19)].
Gao Q
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2020 Apr; 32(2):119-122. PubMed ID: 32458599
[TBL] [Abstract][Full Text] [Related]
4. Chloroquine for COVID-19: rationale, facts, hopes.
Cortegiani A; Ippolito M; Ingoglia G; Einav S
Crit Care; 2020 May; 24(1):210. PubMed ID: 32384908
[No Abstract] [Full Text] [Related]
5. Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine - from HIV-1 infection to COVID-19.
Naghipour S; Ghodousi M; Rahsepar S; Elyasi S
Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1119-1133. PubMed ID: 32631083
[TBL] [Abstract][Full Text] [Related]
6. [Hydroxychloroquine and chloroquine for COVID-19: no evidence of effectiveness].
Vollaard A; Gieling EM; van der Linden PD; Sinha B; de Boer MGJ
Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32749808
[TBL] [Abstract][Full Text] [Related]
7. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Devaux CA; Rolain JM; Colson P; Raoult D
Int J Antimicrob Agents; 2020 May; 55(5):105938. PubMed ID: 32171740
[TBL] [Abstract][Full Text] [Related]
8. [Chloroquine as a possible treatment for COVID-19].
Coumou J; de Vries PJ
Ned Tijdschr Geneeskd; 2020 Mar; 164():. PubMed ID: 32391999
[TBL] [Abstract][Full Text] [Related]
9. Chloroquine paradox may cause more damage than help fight COVID-19.
Sharma A
Microbes Infect; 2020; 22(4-5):154-156. PubMed ID: 32305500
[TBL] [Abstract][Full Text] [Related]
10. [Not Available].
Nau JY
Rev Med Suisse; 2020 Mar; 16(685):510-511. PubMed ID: 32167254
[No Abstract] [Full Text] [Related]
11. Chloroquine and COVID-19, where do we stand?
Lecuit M
Med Mal Infect; 2020 May; 50(3):229-230. PubMed ID: 32217166
[No Abstract] [Full Text] [Related]
12. [Chloroquine phosphate: therapeutic drug for COVID-19].
Mo L; Zheng P
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Apr; 40(4):586-594. PubMed ID: 32895128
[TBL] [Abstract][Full Text] [Related]
13. Insights in Chloroquine Action: Perspectives and Implications in Malaria and COVID-19.
Pillat MM; Krüger A; Guimarães LMF; Lameu C; de Souza EE; Wrenger C; Ulrich H
Cytometry A; 2020 Sep; 97(9):872-881. PubMed ID: 32686260
[TBL] [Abstract][Full Text] [Related]
14. Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?
Sargin G; Yavaşoğlu Sİ; Yavasoglu I
Med Hypotheses; 2020 Jul; 140():109756. PubMed ID: 32344306
[No Abstract] [Full Text] [Related]
15. Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19.
Lei ZN; Wu ZX; Dong S; Yang DH; Zhang L; Ke Z; Zou C; Chen ZS
Pharmacol Ther; 2020 Dec; 216():107672. PubMed ID: 32910933
[TBL] [Abstract][Full Text] [Related]
16. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
Malviya A
Indian Heart J; 2020; 72(2):131-132. PubMed ID: 32534688
[No Abstract] [Full Text] [Related]
17. Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial.
Borba MGS; Val FFA; Sampaio VS; Alexandre MAA; Melo GC; Brito M; Mourão MPG; Brito-Sousa JD; Baía-da-Silva D; Guerra MVF; Hajjar LA; Pinto RC; Balieiro AAS; Pacheco AGF; Santos JDO; Naveca FG; Xavier MS; Siqueira AM; Schwarzbold A; Croda J; Nogueira ML; Romero GAS; Bassat Q; Fontes CJ; Albuquerque BC; Daniel-Ribeiro CT; Monteiro WM; Lacerda MVG;
JAMA Netw Open; 2020 Apr; 3(4):e208857. PubMed ID: 32330277
[TBL] [Abstract][Full Text] [Related]
18. Janus sword actions of chloroquine and hydroxychloroquine against COVID-19.
Chen X; Geiger JD
Cell Signal; 2020 Sep; 73():109706. PubMed ID: 32629149
[TBL] [Abstract][Full Text] [Related]
19. Regulators split on antimalarials for COVID-19.
Jaffe S
Lancet; 2020 Apr; 395(10231):1179. PubMed ID: 32278373
[No Abstract] [Full Text] [Related]
20. COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits.
Halm MA
Am J Crit Care; 2020 Nov; 29(6):489-492. PubMed ID: 32839815
[No Abstract] [Full Text] [Related]
[Next] [New Search]
